Clinical trial
Effects of Hydrogen/Oxygen Mixed Gas Inhalation for Patients With Coronavirus Disease 2019 (COVID-19) Who Had Dyspnea: A Multicenter, Open-label Clinical Trial
NCT04378712 is registered in ClinicalTrials.gov with Guangzhou Institute of Respiratory Disease as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Hydrogen/Oxygen Mixed Gas Inhalation for Patients With Coronavirus Disease 2019 (COVID-19) Who Had Dyspnea: A Multicenter, Open-label Clinical Trial
- Lead sponsor
- Guangzhou Institute of Respiratory Disease
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 21, 2020
- Completion date
- March 23, 2020
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.